Our next steps
Proteolytic enzymes and the lymphatic system
Lymphatics regulate interstitial fluid balance, macromolecule clearance, and immune cell trafficking. In lymphedema and lymphatic dysfunction, protein-rich interstitial fluid, fibrin/fibrinogen fragments, and ECM remodeling (collagens, fibronectin, hyaluronan) increase tissue viscosity and impede flow. Proteolysis is a plausible lever to modify the local protein milieu and reduce resistance to lymph uptake and transport—but it must be precise to avoid harming lymphatic endothelium (LECs) and valves. That’s why the trypsin + chymotrypsin pair (with defined, orthogonal specificities) is the mechanistic centre, while papain/bromelain may serve as broader cysteine-protease complements. Clinical evaluations in preparation.
Proteolytic enzymes and intimate hygiene
Lymphatics regulate interstitial fluid balance, macromolecule clearance, and immune cell trafficking. In lymphedema and lymphatic dysfunction, protein-rich interstitial fluid, fibrin/fibrinogen fragments, and ECM remodeling (collagens, fibronectin, hyaluronan) increase tissue viscosity and impede flow. Proteolysis is a plausible lever to modify the local protein milieu and reduce resistance to lymph uptake and transport—but it must be precise to avoid harming lymphatic endothelium (LECs) and valves. That’s why the trypsin + chymotrypsin pair (with defined, orthogonal specificities) is the mechanistic centre, while papain/bromelain may serve as broader cysteine-protease complements. Clinical evaluations in preparation.
Proteolytic enzymes and intimate hygiene
Protein-rich secretions and exudates support microbial adhesion and biofilm scaffolding. Serine proteases (trypsin + chymotrypsin) hydrolyze proteinaceous deposits and adhesins, potentially easing mechanical removal. Separately, chlorhexidine (CHX) is a well-established antiseptic; multiple in-vitro models (non-gynecologic) report enhanced biofilm disruption when a protease step precedes or accompanies CHX, consistent with matrix opening that improves antiseptic access.
Proteolytic enzymes in topical applications
Chronic wounds often accumulate protein-rich exudate, fibrin slough, denatured ECM, and proteinaceous biofilm matrix, which increase local viscosity, hinder diffusion, and irritate peri-wound skin. Controlled proteolysis is a plausible lever to reduce this protein burden and loosen matrix—directly on the wound bed to ease gentle cleansing, and indirectly on the peri-wound to improve local hygiene and the microclimate associated with healthy microcirculation. Exposure must be precise in dose and time to avoid over-digestion of viable tissue, preserve granulation and the epidermal barrier, and protect capillary integrity. The trypsin + chymotrypsin pair (with defined, orthogonal specificities) remains the mechanistic centre.
